骨转移内分泌治疗的机制 - Suppr

Suppr

超能文献

Mechanisms in endocrine therapy of bone metastases.

作者信息

Stoll B A

出版信息

J R Soc Med. 1985;78 Suppl 9(Suppl 9):11-4.

PMID:4045912

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1289527/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28a4/1289527/6c37e6a918de/jrsocmed00197-0023-a.jpg

相似文献

Mechanisms in endocrine therapy of bone metastases.骨转移内分泌治疗的机制

J R Soc Med. 1985;78 Suppl 9(Suppl 9):11-4.

Comparison of different endocrine therapies in management of bone metastases from breast carcinoma.不同内分泌疗法治疗乳腺癌骨转移的比较

J R Soc Med. 1985;78 Suppl 9(Suppl 9):15-7.

[A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen].[一例经优福定和他莫昔芬有效治疗的多发性骨转移乳腺癌病例]

Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 1):851-4.

[Tamoxifen (Nolvadex): therapeutic effect in metastasizing breast cancer].[他莫昔芬（诺瓦得士）：对转移性乳腺癌的治疗效果]

Ugeskr Laeger. 1979 Jul 30;141(31):2108-13.

The relation between serum calcium and tumor metastases.血清钙与肿瘤转移之间的关系。

Surg Gynecol Obstet. 1969 Feb;128(2):369-74.

Response to aminoglutethimide after failure of tamoxifen therapy in breast cancer.他莫昔芬治疗乳腺癌失败后对氨鲁米特的反应。

South Med J. 1985 Aug;78(8):987-9. doi: 10.1097/00007611-198508000-00024.

[Antiestrogens: a new endocrine treatment possibility in metastasizing breast neoplasms. Experiences of the Swiss Cooperative Cancer Study Group with tamoxifen].

Schweiz Med Wochenschr. 1978 Aug 26;108(34):1317-21.

[Bone metastases of breast cancer. Diagnosis and hormone treatment].[乳腺癌骨转移。诊断与激素治疗]

Strahlentherapie Sonderb. 1964;56:1-147.

Regression of osteoblastic metastases from carcinoma of the prostate following therapy with tamoxifen.他莫昔芬治疗后前列腺癌成骨细胞转移灶的消退

Br J Radiol. 1986 Jul;59(703):703-4. doi: 10.1259/0007-1285-59-703-703.

Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study.

J Clin Oncol. 1994 Aug;12(8):1630-8. doi: 10.1200/JCO.1994.12.8.1630.

引用本文的文献

Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients.雌激素受体、淋巴结及分期作为457例乳腺癌患者复发后生存的预测因素

Br J Cancer. 1987 Dec;56(6):825-9. doi: 10.1038/bjc.1987.298.

Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.他莫昔芬：对其药效学、药代动力学特性及治疗用途的重新评估

Drugs. 1989 Apr;37(4):451-90. doi: 10.2165/00003495-198937040-00004.

本文引用的文献

Oestrogen-receptor status and sites of metastasis in breast cancer.乳腺癌中的雌激素受体状态与转移部位

Br J Cancer. 1981 Sep;44(3):456-9. doi: 10.1038/bjc.1981.205.

Corticosteroids for elderly patients with breast cancer.用于老年乳腺癌患者的皮质类固醇。

Cancer. 1981 Aug 15;48(4):883-7. doi: 10.1002/1097-0142(19810815)48:4<883::aid-cncr2820480404>3.0.co;2-v.

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.他莫昔芬与氨鲁米特治疗晚期乳腺癌的随机交叉试验

Br Med J (Clin Res Ed). 1981 Nov 28;283(6304):1432-4. doi: 10.1136/bmj.283.6304.1432.

Evaluation of tamoxifen dose in advanced breast cancer: a progress report.他莫昔芬治疗晚期乳腺癌剂量的评估：进展报告。

Cancer Treat Rep. 1976 Oct;60(10):1451-9.

Assessment of response to therapy in advanced breast cancer.晚期乳腺癌治疗反应的评估。

Br J Cancer. 1977 Mar;35(3):292-8. doi: 10.1038/bjc.1977.42.

Response of metastatic breast cancer to combination chemotherapy according to site.转移性乳腺癌对联合化疗的部位特异性反应。

Br Med J. 1977 Nov 26;2(6099):1390-1. doi: 10.1136/bmj.2.6099.1390-a.

Tamoxifen in advanced breast cancer.他莫昔芬用于晚期乳腺癌

Cancer Treat Rev. 1978 Sep;5(3):131-41. doi: 10.1016/s0305-7372(78)80017-6.

Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass.通过总骨矿物质质量变化评估甲睾酮对绝经后骨质流失的影响。

Metabolism. 1977 Mar;26(3):267-77. doi: 10.1016/0026-0495(77)90073-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验